Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients
Publication

Publications

Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients

Title
Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients
Type
Article in International Scientific Journal
Year
2016
Authors
Pimenta J
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Title: JACC: Heart FailureImported from Authenticus Search for Journal Publications
Vol. 4
Pages: 736-745
ISSN: 2213-1779
Other information
Authenticus ID: P-00K-VWJ
Abstract (EN): OBJECTIVES The aim of this study was to analyze the prognostic value and attainability of N-terminal pro-brain natriuretic peptide (NT-proBNP) Levels in young and elderly acute decompensated heart failure (ADHF) patients. 0 CrossMark BACKGROUND Less-effective NT-proBNP-guided therapy in chronic heart failure (HF) has been reported in elderly patients. Whether this can be attributed to differences in prognostic value of NT-proBNP or to differences in attaining a prognostic value is unclear. The authors studied this question in ADHF patients. METHODS Our study population comprised 7 ADHF cohorts. We defined absolute (<1,500 ng/L, <3,000 ng/L, <5,000 ng/L, and <15,000 ng/l) and relative NT-proBNP discharge cut-off levels (>30%, >50%, and >70%). Six-month all-cause mortality after discharge was studied for each level in Cox regression analyses, and compared between elderly (age >75 years) and young patients (age <= 75years). Thereafter, we compared percentages of elderly and young patients attaining NT-proBNP levels (= attainability). RESULTS A total of 1,235 patients (59% male, 45% >75 years of age) was studied. Admission levels of NT-proBNP were significantly higher in elderly versus younger patients. The prognostic value of absolute and relative NT-proBNP levels was similar in elderly and young patients. Attainability was significantly lower in elderly patients for all absolute levels and a >50% relative reduction, but not for >30% and >70%. For absolute levels, attainability differences between age groups were decreased to a large extent after correction for admission NT-proBNP and anemia at discharge. For relative levels, attainability differences disappeared after correction for HF etiology and anemia at discharge. CONCLUSIONS In young and elderly ADHF patients, it is not the prognostic value of absolute and relative NT-proBNP levels that is different, but the attainability of these levels that is lower in the elderly. This can largely be attributed to factors other than age. 2016 by the American College of Cardiology Foundation.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 10
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Wet BNP, fluid and hemodynamic status at discharge in acute heart failure - Reply (2010)
Another Publication in an International Scientific Journal
Pimenta J; Paulo, C; Mascarenhas, J; Gomes, A; Azevedo A; Rocha Goncalves, F; Bettencourt P
Validation of a risk score to estimate cardiac risk in subjects from the general population on cardioactive treatment (2008)
Another Publication in an International Scientific Journal
Pimenta J; Bettencourt P; Azevedo A
Time dependent increase in myocardial distensibility after an acute preload elevation (2007)
Other Publications
Pimenta J; Pires, AL; Ladeiras Lopes, R; Monteiro Sousa, D; Brás-Silva C; Leite-Moreira AF
The improvement of cardiac status should be the focus rather than the prevention of worsening renal function in patients admitted for acute decompensated heart failure (2012)
Other Publications
Salah, K; Kok, WEM; Eurlings, LWM; Bettencourt P; Pimenta J; Metra, M; Verdiani, V; Tijssen, JGP; Pinto, YM

See all (61)

Of the same journal

REPLY: Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice (2020)
Another Publication in an International Scientific Journal
Cunningham, JW; Ferreira, JP; Zannad, F
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation (2020)
Another Publication in an International Scientific Journal
Marques, P; Vieira, JT; Flores, L; Ribeiro, A; Faceira, A
Use of the Win Ratio in Cardiovascular Trials (2020)
Article in International Scientific Journal
Ferreira, JP; Jhund, PS; Duarte, K; Claggett, BL; Solomon, SD; Pocock, S; Petrie, MC; Zannad, F; McMurray, JJ
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF (2021)
Article in International Scientific Journal
Ferreira, JP; Verdonschot, J; Wang, P; Pizard, A; Collier, T; Ahmed, FZ; Brunner-La-Rocca, H; Clark, AL; Cosmi, F; Cuthbert, J; Díez, J; Edelmann, F; Girerd, N; González, A; Grojean, S; Hazebroek, M; Khan, J; Latini, R; Mamas, MA; Mariottoni, B...(mais 10 authors)
Prognostic Implications of N-Terminal Pro¿B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved (2022)
Article in International Scientific Journal
Januzzi, JL; Butler, J; Zannad, F; Filippatos, G; Ferreira, JP; Pocock, SJ; Sattar, N; Verma, S; Vedin, O; Iwata, T; Brueckmann, M; Packer, M; Anker, SD

See all (16)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-09-22 at 20:53:16 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book